Posaconazole: An Update of Its Clinical Use
Posaconazole (PCZ) is a relatively new addition to the azole antifungals. It has fungicidal activities against Aspergillus fumigatus, Blastomyces dermatitidis, selected Candida species, Crytopcoccus neoformans, and Trichosporon. PCZ also has fungistatic activities against Candida, Coccidioides, sele...
Main Authors: | Simon Leung, Mara N. Poulakos, Jade Machin |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2015-10-01
|
Series: | Pharmacy |
Subjects: | |
Online Access: | http://www.mdpi.com/2226-4787/3/4/210 |
Similar Items
-
New Drug Formulations of Posaconazole: Brief Clinical Pharmacology Review
by: Veselov A.V.
Published: (2016-11-01) -
Posaconazole
by: Bhattacharya M, et al.
Published: (2010-01-01) -
Pharmacokinetic/pharmacodynamic study of posaconazole delayed-release tablet in a patient with coexisting invasive aspergillosis and mucormycosis
by: Leelawattanachai P, et al.
Published: (2019-04-01) -
Posaconazole: A Review of Drug Interactions with HIV Antiretroviral Agents
by: Mara Poulakos, et al.
Published: (2014-03-01) -
Pharmacokinetics and safety of posaconazole delayed-release tablets for invasive fungal infections
by: Wiederhold NP
Published: (2015-12-01)